Cargando…

Efficient Uptake of Recombinant Lipidated Survivin by Antigen-Presenting Cells Initiates Antigen Cross-Presentation and Antitumor Immunity

Survivin is overexpressed in various types of human cancer, but rarely expressed in terminally differentiated adult tissues. Thus, survivin is a potential target antigen for a cancer vaccine. However, self-tumor-associated antigens are not highly immunogenic. Bacteria-derived lipoproteins can activa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Chen-Yi, Chen, Yi-Jyun, Wu, Chiao-Chieh, Liu, Shih-Jen, Leng, Chih-Hsiang, Chen, Hsin-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932405/ https://www.ncbi.nlm.nih.gov/pubmed/29755461 http://dx.doi.org/10.3389/fimmu.2018.00822

Ejemplares similares

Delivery of Antigen to CD8(+) Dendritic Cells by Fusing Antigen With Formyl Peptide Receptor-Like 1 Inhibitor Protein Induces Antitumor Immunity
por: Chiang, Chen-Yi, et al.
Publicado: (2019)

A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population
por: Wu, Chiao-Chieh, et al.
Publicado: (2016)

A Novel Recombinant Fcγ Receptor-Targeted Survivin Combines with Chemotherapy for Efficient Cancer Treatment
por: Wu, Chiao-Chieh, et al.
Publicado: (2021)

Intranasal Vaccination With Recombinant Antigen-FLIPr Fusion Protein Alone Induces Long-Lasting Systemic Antibody Responses and Broad T Cell Responses
por: Hsieh, Ming-Shu, et al.
Publicado: (2021)

Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy
por: Chang, Li-Sheng, et al.
Publicado: (2014)

Presenting lipid antigens
por: LeBrasseur, Nicole
Publicado: (2005)

Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro
por: Ghimire, Tirth R., et al.
Publicado: (2012)

Recombinant lipidated Zika virus envelope protein domain III elicits durable neutralizing antibody responses against Zika virus in mice
por: Chen, Mei-Yu, et al.
Publicado: (2020)

Activation of GM-CSF and TLR2 signaling synergistically enhances antigen-specific antitumor immunity and modulates the tumor microenvironment
por: Yan, Wan-Lun, et al.
Publicado: (2021)

Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy
por: Huang, Chung-Hsiung, et al.
Publicado: (2016)

Ceramide Inhibits Antigen Uptake and Presentation by Dendritic Cells
por: Sallusto, Federica, et al.
Publicado: (1996)

Mechanism of Antigen Presentation and Specificity of Antibody Cross-Reactivity Elicited by an Oligosaccharide-Conjugate Cancer Vaccine
por: Wang, Szu-Wen, et al.
Publicado: (2023)

Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
por: Chiang, Chen-Yi, et al.
Publicado: (2016)

Antigen-Presenting Cells and Antigen Presentation in Tertiary Lymphoid Organs
por: Hughes, Catherine E., et al.
Publicado: (2016)

Liposomal TLR9 Agonist Combined with TLR2 Agonist-Fused Antigen Can Modulate Tumor Microenvironment through Dendritic Cells
por: Shen, Kuan-Yin, et al.
Publicado: (2020)

Lineage Switch Macrophages Can Present Antigen
por: Bretz, James D., et al.
Publicado: (1992)

Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting Cells
por: Shrestha, Bishwas, et al.
Publicado: (2020)

Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein
por: Ho, Tin-Yun, et al.
Publicado: (2004)

Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies
Publicado: (1991)

FcγR-mediated uptake and processing of antigen–immunoglobulin complexes by professional antigen-presenting cells
por: de Jong, JMH, et al.
Publicado: (2005)

Fc Gamma Receptors and Their Role in Antigen Uptake, Presentation, and T Cell Activation
por: Junker, Fabian, et al.
Publicado: (2020)

The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells
por: Harryvan, Tom J., et al.
Publicado: (2021)

Presentation of hepatocellular antigens
por: Grakoui, Arash, et al.
Publicado: (2016)

Antigen Presentation in the Lung
por: Kawasaki, Takumi, et al.
Publicado: (2022)

Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells
por: Lubich, Christian, et al.
Publicado: (2022)

Dendritic cell-based vaccine prepared with recombinant Lactococcus lactis enhances antigen cross-presentation and antitumor efficacy through ROS production
por: Zhang, Tingting, et al.
Publicado: (2023)

Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
por: Alloatti, Andrés, et al.
Publicado: (2017)

Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism
por: Patel, Jaina M., et al.
Publicado: (2019)

Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes
Publicado: (1992)

Three-day dendritic cells for vaccine development: Antigen uptake, processing and presentation
por: Bürdek, Maja, et al.
Publicado: (2010)

Characterization of c-Maf(+)Foxp3(−) Regulatory T Cells Induced by Repeated Stimulation of Antigen-Presenting B Cells
por: Chien, Chien-Hui, et al.
Publicado: (2017)

A Purified Recombinant Lipopeptide as Adjuvant for Cancer Immunotherapy
por: Song, Ying-Chyi, et al.
Publicado: (2014)

Correction: Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
por: Alloatti, Andrés, et al.
Publicado: (2018)

CD206(+) tumor-associated macrophages cross-present tumor antigen and drive antitumor immunity
por: Modak, Madhura, et al.
Publicado: (2022)

Inhibition of endocytic lipid antigen presentation by common lipophilic environmental pollutants
por: Sharma, Manju, et al.
Publicado: (2017)

Biocompatible Lipid Polymer Cationic Nanoparticles for Antigen Presentation
por: Pérez-Betancourt, Yunys, et al.
Publicado: (2021)

Structured particles for antigen presentation
por: Buonaguro, L, et al.
Publicado: (2006)

Antigen presentation to B cells
por: Harwood, Naomi E, et al.
Publicado: (2010)

Antigen Presentation by Vascular Cells
por: Pober, Jordan S., et al.
Publicado: (2017)

Genetics of antigen processing and presentation
por: Kelly, Adrian, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0mfpqubvu1mfpjl1eoocnt6485